Pharmaceutical manufacturing company, Venus Remedies, has reported result for third quarter ended December 31, 2012.
The company’s net profit for the quarter jumped by 55.37% at Rs 16.05 crore as compared to Rs 10.33 crore for the same quarter in the previous financial year. Total income from operation of the company rose by 17.54% at Rs 112.63 crore for quarter under review as compared to Rs 95.82 crore for the quarter ended December 31, 2011.
Venus Remedies is a pharmaceutical manufacturing company. The company provides formulations in area of antibiotics and oncological therapeutics. The company has two manufacturing facilities located in India and Germany. It manufactures Oncological and Cefelosporine Injectable products.
